Aberrant expression of UBE2C leads to the degradation of pVHL (von Hippel-Lindau tumor suppressor), which increases HIF-1α levels, resulting in endothelial inflammation and epithelial-mesenchymal transition in calcific aortic valve disease [27]. The gene discussed is HIF1A; the disease is aortic valve calcification.